logo

For the Inventor, By the Inventor

Blacksburg, VA, United States of America

Intrexon Corporation


USPTO Granted Patents = 121

% Expired Patents = 77.7



Trademarks = 2

Forward Citations = 936

Loading Chart...
Loading Chart...

82 inventors (with patents filed for the assignee):

goldMedal Thomas David Reed (41 out of 48 patents)

silverMedal Robert Eugene Hormann (35 out of 44 patents)

bronzeMedal Subba Reddy Palli (30 out of 36 patents)

4.  Dean Ervin Cress (17 out of 21 patents)

5.  Orestes Chortyk (14 out of 14 patents)

6.  Colin M Tice (14 out of 68 patents)

7.  Amy Hobbs Atzel (12 out of 13 patents)

8.  Glenn Richard Carlson (10 out of 19 patents)

9.  Mohan Basavaraju Kumar (8 out of 10 patents)

10.  Tarlochan Singh Dhadialla (8 out of 11 patents)

11.  Inna Shulman (7 out of 23 patents)

12.  David W Potter (7 out of 8 patents)

13.  Andrew Meyer (7 out of 7 patents)

14.  Thomas R Opie (7 out of 10 patents)

15.  Robert Beech (6 out of 8 patents)


Core Competencies:
Ecdysone Receptor
Gene Expression
Biotherapeutics
Serine Recombinases
Diacylhydrazine
Immunomodulators
Transgene Expression
Modulation
Protein Production
Chimeric Receptors
Ligands
Disease Diagnosis

121 patents:

1. 10851119 - Boron-containing diacylhydrazines (2020-12-01),
2. 10648003 - Site-specific serine recombinases and methods of their use (2020-05-12),
3. 10633361 - Chiral diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex (2020-04-28),
4. 10584351 - Vectors conditionally expressing therapeutic proteins, host cells comprising the vectors, and uses thereof (2020-03-10),
5. 10570158 - Boron-containing diacylhydrazine compounds (2020-02-25),
6. 10501405 - Crystalline diacylhydrazine and the use thereof (2019-12-10),
7. 10464951 - Boron-containing diacylhydrazines (2019-11-05),
8. 10314926 - Therapeutic gene-switch constructs and bioreactors for the expression of biotherapeutic molecules, and uses thereof (2019-06-11),
9. 10190124 - Substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system (2019-01-29),
10. 10131916 - Regulatory element for heterologous protein production in the fruiting body of filamentous fungi (2018-11-20),
11. 10087231 - Substitution mutant receptors and their use in an ecdysone receptor-based inducible gene expression system (2018-10-02),
12. 10081817 - Site-specific serine recombinases and methods of their use (2018-09-25),
13. 10046049 - Engineered cells expressing multiple immunomodulators and uses thereof (2018-08-14),
14. 10036026 - Methods for dynamic vector assembly of DNA cloning vector plasmids (2018-07-31),
15. 9944659 - Boron-containing diacylhydrazine compounds (2018-04-17),
Intrexon Corporation is a biotechnology company that designs and engineers living systems to address the world's greatest challenges. With proprietary synthetic biology technologies and expertise, Intrexon aims to create gene-based solutions in healthcare, agriculture, energy, and environmental sectors. Their innovations include the development of genetically modified organisms, biotherapeutics production, and insect control strategies.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

Intrexon Corporation
121 Patents

#2 in Blacksburg, VA

#54 in Virginia

#3,194 in US

#6,600 in the World

Blacksburg, VA (US)
Blacksburg, VA, United States of America

Intrexon Corporation

Forward Citations = 936

82 inventors:

goldMedal Thomas David Reed (41 out of 48 patents)

silverMedal Robert Eugene Hormann (35 out of 44 patents)

bronzeMedal Subba Reddy Palli (30 out of 36 patents)

4.  Dean Ervin Cress (17 out of 21 patents)

5.  Orestes Chortyk (14 out of 14 patents)

Please report any incorrect information to [email protected]
Loading…